SCHEMBL6993979

SCHEMBL6993979

COC(=O)c1n[nH]c(C(=O)OC)c1N

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.65
NPSR1 Q6W5P4 3/20 0.45
KDM4E B2RXH2 5/20 0.45
STAT3 P40763 1/20 0.45
HIF1A Q16665 1/20 0.45
ALDH1A1 P00352 9/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.41
HSD17B10 Q99714 5/20 0.40
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 3/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 2/20 0.36
USP2 O75604 1/20 0.36
ALOX15 P16050 1/20 0.36
TP53 P04637 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PKM P14618 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993983 0.89 KDM4C (0.56) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL28954025 0.86 KDM4C (0.53) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL1009945 0.82 KDM4C (0.52) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL7378141 0.82 KDM4C (0.45) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL28954059 0.79 KDM4C (0.49) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL3144307 0.78 KDM4C (0.67) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL18660404 0.78 KDM4C (1.00) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL18560457 0.77 KDM4C (0.65) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL29749406 0.77 KDM4C (0.65) KDM4CNPSR1KDM4ESTAT3HIF1A
SCHEMBL6689443 0.77 KDM4C (0.46) KDM4CNPSR1KDM4ESTAT3HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123296-B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LTD (GB) 2003-09-17 EP disclosed
US-6333330-B1 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. 2001-12-25 US disclosed
EP-1123296-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION Pfizer Limited (GB) 2001-08-16 EP disclosed
WO-2000024745-A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LIMITED (GB) 2000-05-04 WO disclosed